Download Citation
Article Source:
Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
Park H,
Byun JM,
Yoon SS,
Koh Y,
Yoon SW,
et al.
(2022)
Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM.
PLOS ONE 17(1): e0260113.
https://doi.org/10.1371/journal.pone.0260113